Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03390270 · ClinicalTrials.gov registry record
Risk-score Based ICU Triage
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 462
- Enrollment target
NCT03390270: Completed study, sponsored by Duke University.
NCT03390270 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 462 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03390270 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 462 participants
- Enrollment target
Study Summary
The investigators have created a new risk score that predicts whether initially stable patients with myocardial infarctions (heart attacks) will require intensive care while they are in the hospital. To evaluate how well this risk score works, the investigators plan to calculate this risk score for every patient that comes to the hospital with a heart attack, provide the risk score to the emergency room doctor treating the patient, and determine whether each patient required intensive care while they were in the hospital. The investigators will then evaluate whether giving emergency room doctors access to this risk score reduced costs of taking care of heart attack patients compared with previous years.
Primary Outcome
Cost of caring for NSTEMI patients at Duke University Hospital in the 1 year prior to roll-out of the risk score versus the 1 year after
Interventions
- OTHER Admission with NSTEMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 462 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2019-08-31 |
What the finished NCT03390270 record still lists
NCT03390270 is an observational study that tracks outcomes without assigning an intervention. The registered 462 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Admission with NSTEMI is the first listed.
NCT03390270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03390270 about?
NCT03390270 is a clinical study titled "Risk-score Based ICU Triage". The investigators have created a new risk score that predicts whether initially stable patients with myocardial infarctions (heart attacks) will require intensive care while they are in the hospital. To evaluate how well this risk score works, the investigators plan to calculate this risk score for ...
What is the current status of trial NCT03390270?
This trial is currently completed. The enrollment target is 462 participants. The study started on 2018-02-14. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03390270?
The interventions under investigation include: Admission with NSTEMI (OTHER).
Who is sponsoring clinical trial NCT03390270?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00949819 · 462 participants
Active Surveillance for Cancer of the Prostate (ASCaP)
- NCT05126277 · 462 participants · Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
- NCT04546399 · 461 participants · Phase 2
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI